148 related articles for article (PubMed ID: 28977305)
1. ASSESSMENT OF THE LATE EFFECTS ON BONES AND ON BODY COMPOSITION OF CHILDREN AND ADOLESCENTS TREATED FOR ACUTE LYMPHOCYTIC LEUKEMIA ACCORDING TO BRAZILIAN PROTOCOLS.
Molinari PCC; Lederman HM; Lee MLM; Caran EMM
Rev Paul Pediatr; 2017; 35(1):78-85. PubMed ID: 28977305
[TBL] [Abstract][Full Text] [Related]
2. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood.
van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
Med Pediatr Oncol; 2000 Oct; 35(4):415-20. PubMed ID: 11025472
[TBL] [Abstract][Full Text] [Related]
4. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Jain S; Jain S; Kapoor G; Virmani A; Bajpai R
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27671543
[TBL] [Abstract][Full Text] [Related]
5. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects on bone mineral density of different therapeutic schemes for acute lymphoblastic leukemia or non-Hodgkin lymphoma during childhood.
Benmiloud S; Steffens M; Beauloye V; de Wandeleer A; Devogelaer JP; Brichard B; Vermylen C; Maiter D
Horm Res Paediatr; 2010; 74(4):241-250. PubMed ID: 20395671
[TBL] [Abstract][Full Text] [Related]
7. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
[TBL] [Abstract][Full Text] [Related]
8. Body composition in long-term survivors of acute lymphoblastic leukemia diagnosed in childhood and adolescence: A focus on sarcopenic obesity.
Marriott CJC; Beaumont LF; Farncombe TH; Cranston AN; Athale UH; Yakemchuk VN; Webber CE; Barr RD
Cancer; 2018 Mar; 124(6):1225-1231. PubMed ID: 29231963
[TBL] [Abstract][Full Text] [Related]
9. Skeletal morbidity in childhood acute lymphoblastic leukemia.
Mandel K; Atkinson S; Barr RD; Pencharz P
J Clin Oncol; 2004 Apr; 22(7):1215-21. PubMed ID: 15051768
[TBL] [Abstract][Full Text] [Related]
10. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia.
van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
J Pediatr; 2002 Aug; 141(2):204-10. PubMed ID: 12183715
[TBL] [Abstract][Full Text] [Related]
11. Effect of calcium intake, tennis playing, and body composition on bone-mineral density of Brazilian male adolescents.
Juzwiak CR; Amancio OM; Vitalle MS; Szejnfeld VL; Pinheiro MM
Int J Sport Nutr Exerc Metab; 2008 Oct; 18(5):524-38. PubMed ID: 19033613
[TBL] [Abstract][Full Text] [Related]
12. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia.
Gunes AM; Can E; Saglam H; Ilçöl YO; Baytan B
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e102-7. PubMed ID: 20216235
[TBL] [Abstract][Full Text] [Related]
13. Predictors of low and very low bone mineral density in long-term childhood acute lymphoblastic leukemia survivors: Toward personalized risk prediction.
Nadeau G; Samoilenko M; Fiscaletti M; Veilleux LN; Curnier D; Laverdière C; Sinnett D; Krajinovic M; Lefebvre G; Alos N
Pediatr Blood Cancer; 2024 Aug; 71(8):e31047. PubMed ID: 38736190
[TBL] [Abstract][Full Text] [Related]
14. Relationships of Bone Mineral Density to Whole Body Mass, Fat Mass and Fat-free Mass in Long-term Survivors of Acute Lymphoblastic Leukemia in Childhood.
Athale UH; Marriott CJC; Cranston A; McDonald P; Webber CE; Farncombe TH; Barr RD
J Pediatr Hematol Oncol; 2021 Jan; 43(1):12-17. PubMed ID: 32675554
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density in children with acute lymphoblastic leukemia.
Inaba H; Cao X; Han AQ; Panetta JC; Ness KK; Metzger ML; Rubnitz JE; Ribeiro RC; Sandlund JT; Jeha S; Cheng C; Pui CH; Relling MV; Kaste SC
Cancer; 2018 Mar; 124(5):1025-1035. PubMed ID: 29266176
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia.
te Winkel ML; van Beek RD; de Muinck Keizer-Schrama SM; Uitterlinden AG; Hop WC; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2010 May; 95(5):752-9. PubMed ID: 20015871
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Papageorgiou T; Papastergiou C; Tsituridis I; Koliouskas D
Turk J Pediatr; 2006; 48(2):101-4. PubMed ID: 16848106
[TBL] [Abstract][Full Text] [Related]
18. Is the treatment for childhood solid tumors associated with lower bone mass than that for leukemia and Hodgkin disease?
Muszynska-Roslan K; Konstantynowicz J; Panasiuk A; Krawczuk-Rybak M
Pediatr Hematol Oncol; 2009 Jan; 26(1):36-47. PubMed ID: 19206007
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
[TBL] [Abstract][Full Text] [Related]
20. [Leptin, body composition and bone mineralization in children after treatment for Wilms tumor].
Muszyńska-Rosłan K; Krawczuk-Rybak M; Konstantynowicz J; Wołczyński S; Siedlecka E
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):53-8. PubMed ID: 15355740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]